Article 25 Jul 2022 In Through The Out Door: FDA Issues Guidance On Its Importation Of Prescription Drugs Final Rule United States Healthcare
Article 14 Jul 2022 It's A Heartache: FDA's OPDP Issues An Untitled Letter For Unlawful Promotion Of A Cholesterol-Lowering Drug Product United States Healthcare
Article 14 Jul 2022 Break On Through To The Other Side, Part 2: FDA Issues Draft Guidance About Breakthrough Therapy Designation Rescission United States Healthcare
Article 28 Apr 2022 A Change Is Gonna Come: AdvaMed Revises Its Code Of Ethics On Interactions With Health Care Professionals United States Healthcare
Article 19 Apr 2022 Out Of Touch: FDA Takes Exception With Drug Company's Promotion For Topical Drug Product United States Healthcare
Article 31 Mar 2022 Roll With The Changes: FDA's Proposed Amendments To Converge Its Quality Management System Requirements With ISO Requirements United States Healthcare
Article 30 Mar 2022 What's That Smell? California Safe Cosmetics Program Wants To Know United States Healthcare
Article 04 Mar 2022 Slow Down, You Move Too Fast: OPDP Issues A Warning Letter For Promoting An Investigational New Drug United States Healthcare
Article 04 Mar 2022 The Room Where It Happens: FDA Issues Draft Guidance On Formal Meetings Between FDA And Sponsors Of OTC Monograph Drugs United States Healthcare